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Abstract Archeological findings give profound evidence
that humans have suffered from kidney and bladder stones
for centuries. Bladder stones were more prevalent during
older ages, but kidney stones became more prevalent during
the past 100 years, at least in the more developed countries.
Also, treatment options and conservative measures, as well
as ‘surgical’ interventions have also been known for a long
time. Our current preventive measures are definitively com-
parable to those of our predecessors. Stone removal, first
lithotomy for bladder stones, followed by transurethral
methods, was definitively painful and had severe side effects.
Then, as now, the incidence of urolithiasis in a given
population was dependent on the geographic area, racial
distribution, socio-economic status and dietary habits.
Changes in the latter factors during the past decades have
affected the incidence and also the site and chemical
composition of calculi, with calcium oxalate stones being
now the most prevalent. Major differences in frequency of
other constituents, particularly uric acid and struvite, reflect
eating habits and infection risk factors specific to certain
populations. Extensive epidemiological observations have
emphasized the importance of nutritional factors in the
pathogenesis of urolithiasis, and specific dietary advice is,
nowadays, often the most appropriate for prevention and
treatment of urolithiasis.
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Introduction
Although less frequent than adult stone disease, urolithiasis
in the pediatric age group plays an important and increasing
role, not only in parts of the world with a high incidence of
stone disease such as the Near and Far East, but also in the
industrialized countries [1]. Pediatric urolithiasis is associ-
ated with significant morbidity, particularly since stones
tend to recur, and, thus, should not be underestimated. Even
though great progress has been achieved during the past
few decades in a better understanding of the etiology,
pathophysiology, treatment and prevention of urolithiasis,
many aspects still remain controversial and also depend on
obvious regional diversities of stone disease.
Urolithiasis has become more common in children over
the past few decades as a result of rapid variations in habits
and increasing affluence. Changing socio-economic con-
ditions have generated changes in the incidence and type of
urolithiasis in terms of both the site and the physico-
chemical composition of the calculi. Major variations in
worldwide occurrence of urolithiasis have been reported,
according to geographical areas and historical periods.
This teaching paper focuses on historical knowledge
about recurrent stone disease and aims to clarify differences
in epidemiologic data in different regions of the world.
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Kidney stone disease has been a well-known entity for
centuries. This has been markedly established by different
archeological findings, as well as by writings about painful
stone colic and therapeutic trials for stone removal [2]. In
ancient centuries urolithiasis was often a disastrous disease,
with a catastrophic outcome all too often leading to the
patient’s death.
Examinations of Egyptian mummies have revealed
kidney and bladder stone disease. For example, in 1901,
the English archeologist E. Smith found a 5,000-year-old
bladder stone at the funeral site of El Amrah, Egypt [2, 3].
However, he reported only four cases of urolithiasis in
thousands of examined mummies, which led to the con-
clusion that stone disease must have been less prevalent in
ancient Egypt. Regimens for treatment of diseases of the
urinary tract, including stones, had already been found in
the papyrus Ebers (1500 BC), being the main origin of our
knowledge of old traditional Egyptian medicine. Although
the ancient Egyptians were famous for their mummifying
techniques, they obviously did not know how to remove
kidney or bladder stones [2].
Already in ancient Mesopotamia, knowledge of soluble
or insoluble (bladder) stones was available. On various
stone tablets, recipes for treatment of different diseases,
such as the dissolution of soft kidney and bladder stones,
were found. Saltpeter and turpentine oil were known to
increase urine production, and pulverized egg-shell, mainly
from ostrich eggs, with a high content of calcium carbonate,
was ingested to bind lithogenic substances [3, 4]. The harder
stones were left for surgical treatment. Hence, our typical
current treatment options, and even invasive interventions
such as urethral catheterization, were already ‘available’
centuries ago [3, 5]. A specific correlation between urinary
tract infection and the development of stones was reported
in neither ancient Egypt nor Mesopotamia, although
dysuria, hematuria and pyuria were observed, and urethral
catheterization in patients with urinary retention, e.g. due to
gonorrheal urethritis, was performed.
Uroscopy, for example, was also known as a fundamen-
tal diagnostic evaluation, as were diseases of the urinary
tract such as bladder or kidney calculi, both already
mentioned in the Hippocratic collection five centuries BC
[3, 5]. Three centuries BC, Ammonius first mentioned that
crushing a bladder stone would make its removal much
easier, for which he received his nickname “Lithotomus” =
Stein-Schneider (stone cutter) [3]. Regardless of his revolu-
tionary thoughts, surgical procedures for stone removal
only became popular centuries later.
Detailed medical literature is also known from ancient
India. In the sixth century BC, Sushruta, the main physician
to the king of India, first reported in his series of volumes,
the Sushruta-Samshita, stone removal via the urethra using
a splint. Next, he reported on urolithiasis and its compli-
cations, such as infection, anuria and uremia, hence a
mostly disastrous outcome in patients with stones. Another
famous Hindu author, Charaka, reported in his Samshita on
instrumental removal of urethral stones. Sushruta later
recommended the so-called Steinschnitt (stone cut) for the
treatment of bladder stones. Because many patients died
under this procedure, it was only allowed after consent had
been given by the sovereign, but it was the only possibility
for helping those who had been suffering from severe and
ongoing colicky pain for a long time. As this procedure
needed skillful undertaking, the profession of the traveling
Stein-Schneider (stone cutter, people who removed urinary
stones) was later born. These new specialists continued to
travel throughout Europe until the late eighteenth century.
The knowledge from ancient India possibly reached
central Europe via Persia and ancient Greece. Hippocrates
had profound knowledge of stone disease and well de-
scribed the clinical symptoms of bladder stones. One of the
most known Stein-Schneider of the Alexandrine epoch,
who lived around 280 BC, introduced a lithotripsy proce-
dure for the treatment of bladder stones. However, such
stone removal procedures were originally prohibited by the
Hippocratic Oath, possibly due to the severe risks of the
procedure [6]. Complications observed at this time were
high fevers, urinary fistulas, impotence due to the perineal
approach, and even death. Working men (surgeons), who
were then not bound by the Hippocratic Oath, were hence
the only persons able to perform such procedures.
Since the first century BC, ancient Greek medicine had
become available in the Roman Empire. One of the most
known physicians of this time was Aulus Cornelius Celsus
(ca. 25 BC–ca. 50 AD), who tried to include all medical
knowledge into an encyclopedia. In this book he reported
on the typical (colicky) abdominal pain of patients with
urolithiasis, but he also described the ‘Steinschnitt’ proce-
dure with a perineal incision, which was called the Celsic
method and was used up until the late eighteenth century
[3, 6]. He recommended that the patient take a long walk
and a specific diet before the procedure finally took place
after a 1-day fast in a warm room. He also reported on
complications, mostly resembling the typical signs of
urosepsis, but also post-operative bleeds, fistulas, bladder
tamponade, etc. Most of the patients so treated were boys
aged 9−14 years, a fact that later led to the postulation that
kidney disease was most prevalent in this age group. At the
end of the Roman Empire the methods of ancient Greek
medicine were lost in Europe. The monks, respected as the
‘intellectuals’ of the fifth to twelfth centuries, were the only
persons still knowing and performing the ‘old’ medical
procedures, and the monasteries were the only places where
such procedures were performed.
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dures were also known and were frequently reported by
Rhazes (865–925) and Ibn Sina (Avicenna, 980–1037), but
especially from Abulcasis (936–1013 AD), who worked in
Cordova, Spain, under the caliphate of the Omijades. He
recommended treating only the good diseases, not the bad
ones, a measure to prevent bad opinions about doctors. In
60 chapters of his first book, “Surgery”, he reported on
bladder and urethral stones, mostly in agreement with his
predecessor Celsus [7]. He used clysters before lithotomy
and discussed the difficult removal of huge bladder stones
in detail. In contrast to Ammonius, he started using a stone
caliper and also introduced a ligature around the penis to
prevent backward sliding of a urethral stone during the
removal procedure. Next, he seemed to be the first physician
to crush stones within the urethra by means of an ancestor of
the currently used lithotripter. Abulcasis also mentioned
stone removal procedures in female patients, which, howev-
er, were not performed by him, but by midwives.
As mentioned above, the monks, respected as the
‘intellectuals’ of the fifth to twelfth centuries, were still
performing the ‘old’ medical procedures for stone preven-
tion and removal. Under Charles the Great (768–814) the
European monasteries were built up as medical centers [8].
The oldest available handbook from this time is the Codex
Bambergensis medicinalis 1, which also included urological
prescriptions for treatment of urinary stones, as well as
enuresis, bladder and kidney pain. Usually only people
living in the monastery were treated. However, some
monks were so renowned that even high-ranking people,
e.g. emperor Heinrich II (973–1024), who suffered from
renal stones, were repeatedly treated and even operated on
(bladder stone). Hildegard from Bingen (1098–1179),
abbess and the first writing female physician, wrote one
famous and later subdivided book (Liber simplicis et liber
compositae medicinae), which also dealt with urological
diseases and treatment availabilities [9]. She already
recognized the modern ‘metabolic syndrome’ as one reason
for stone disease next to the then typical notion of infection
as the reason for stone disease. However, with her, the
epoch of ‘monastery medicine’ came to an end, and, finally,
with the fourth Lateran Council, the secularization of
medicine was induced.
Treatment of bladder stones was popular in the sixteenth
to eighteenth centuries, especially because of the traveling
Stein Schneider. The prevalence of kidney stone disease did
increase during that time and was found throughout all ages
and social groups. The reason for that was the change in
nutritional habits. After the pest epidemics, nutrition
improved in the sixteenth century, with a steady increase
in calorie intake [3]. A comparable situation was found
after The Thirty Years’ War, during the second half of the
seventeenth century and at the beginning of the 18th
century. Another very important risk factor explaining the
increase in kidney stone prevalence is the increased intake
of alcoholic beverages and, especially, that of wine or must,
which was a common drink during that time in all social
groups, at least in Europe.
During the late seventeenth century Frère Jacques
Beaulieu (1651–1714) even treated patients in the royal
household of Louis XIV., as well as those in the well-
known hospitals “Hotel Dieu” and “Charité” in Paris.
Although he was not a monk, he used the title Frère to
appear more trustworthy. As most of the stone removal
procedures were unsuccessful or were accompanied by
severe side effects, mostly resulting in the patient’s death,
he fled from the royal household. However, later, he was
the first person to use the lateral approach for a perineal
lithotomy, which he had invented together with Johann
Jakob Rau as “sectio lateralis” [2]. He then performed
approximately 5,000 lithotomies, but unfortunately his
method was still accompanied by severe morbidity and
mortality [10]. As this stone removal procedure was very
painful and combined with great mortality, it was only
accepted as the final way of treatment, “an act of pure
faith”, as Herman Boerhaave (1668–1738), another impor-
tant figure of medicine during that era, postulated. He
published a booklet, “Metaphylactic Advice”, which rec-
ommended an increase in fluid intake, a hot bath for
vasodilatation, and exercise to induce stone passage [11]. A
specific anecdote from this time is a composition by Marin
Marais (1656–1728), a French composer, who described
the removal of his bladder stone in a musical piece for bass
viol [12]. Worth mentioning also is that bladder stone
sufferers even applied lithotomy to themselves, for exam-
ple, Jan de Dost, a Dutchman living in the seventeenth
century. Others marked the day of stone removal more than
their annual anniversary, or invented devices to ease their
pain (e.g. Benjamin Franklin 1706–1790) [13].
At the end of the eighteenth century, determination of
stone composition, as well as urinary constituents, became
possible. This led to the finding of (increased) excretion of
uric acid in urine and of uric acid as a common stone
component by Scheele [14]. Later, various other determi-
nants of kidney stone disease were unraveled, with calcium
and oxalate being the more prevalent, but also the more
rarely found substances like xanthine or cystine [15]. Next,
stone analysis gave evidence that most of the bladder stone
patients were boys less then 10 years of age. For example,
of 1,463 patients with calcium phosphate stones, 950
(∼65%) were below 10 years of age [16]. Surprisingly, how-
ever, this progress in ‘stone research’ was soon forgotten,
and most of the research done thereafter was focused on
clinical pathology instead.
On 13 January 1824, Jean Civiale (1792–1876) first
presented a lithotryptic instrument, which enabled him to
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the Neckar Hospital in Paris [16]. He then collected the data
of patients from all over Europe to show the superiority of
his method over the lithotomy procedure, expressing a one
in five mortality rate for lithotomy and a significantly lower
mortality rate under the usage of the transurethral instru-
ment, in 1826. However, it is worthwhile mentioning that
the latter method was only used in patients with smaller
stones that were within reach [13].
Historical evidence has shown a significant increase in
kidney stones during the past 100 years, with the exception
of the two World Wars. In contrast, the incidence of bladder
stones decreased, but only in the developed world. How-
ever, a fundamental reason, especially for the latter
development, cannot be presented. Could it be an interaction
of changes in nutrition, vitamin supplementation, fluid
intake, or the reduction of urinary tract infections? Never-
theless, bladder stone disease still remains a significant
medical problem in the developing world.
Since the early days, people have wanted to treat kidney
stone disease by conservative measures. In this respect a
variety of plant ingredients were used, which, according to
our experiences today, would lead to an increase in urine
volume or reduced pain, or had anti-inflammatory compo-
nents [3]. Hence, today’s (pediatric) nephrologists’ ap-
proach to stone prevention instead of repeated—although
now easy—stone removal is based on historical grounds.
Nevertheless, stone disease differed, and still differs,
through geographic, socio-economic and even religious
boundaries.
Differences in epidemiology
Geographical distribution
The overall probability that an individual will form stones
varies in different parts of the world. The risk of developing
urolithiasis in adults appears to be higher in the western
hemisphere (5–9% in Europe, 12% in Canada, 13–15% in
the USA) than in the eastern hemisphere (1–5%), although
the highest risks have been reported in some Asian
countries such as Saudi Arabia (20.1%) [17, 18]. The
incidence of urolithiasis in a given population is dependent
on the geographic area, racial distribution, and socio-
economic status of the community. Changes in socio-
economic conditions over time, and the subsequent changes
in dietary habits, have affected not only the incidence but
also the site and chemical composition of calculi. Reno-
ureteral calculosis featuring mainly calcium oxalate and
phosphate is currently more frequent in economically
developed countries, whereas vesical calculosis is fairly
widespread in Asia, with calculi composed of ammonium
urate and calcium oxalate [19]. An epidemiology study by
Asper reveals that the occurrence of urolithiasis in the
nineteenth century population in Europe was quite similar
to that of the twentieth century in Asia [20]. The analogy
was demonstrated for age distribution, stone localization,
male/female ratio, and stone composition according to the
variables defined in Table 1.
Stone composition has changed substantially over the
past decades, with a progressive increase in frequency of
calcium oxalate and calcium phosphate stones, even in the
eastern hemisphere, where these stones have been tradi-
tionally less frequent than uric acid and infection stones.
Recent epidemiology studies from different continents and
countries report that calcium oxalate accounts for 60% to
90% of stones in children, followed by calcium phosphate
(10–20%), struvite (1–14%), uric acid (5–10%), cystine (1–
5%), and mixed or miscellaneous (4%) [21–35].
Hypercalciuria is recognized worldwide as the most
frequent underlying factor in calcium oxalate stones,
although, in some countries of the eastern hemisphere,
hypocitraturia has been reported as the leading cause [36,
37]. Other less frequent metabolic risk factors reported in
these studies are hyperuricosuria and hyperoxaluria. How-
ever, increased urinary oxalate excretion might be under-
estimated and might even be a more prevalent risk factor
than hypercalciuria for stone disease in some populations
(our own experience).
Struvite or infection-related stones, very common in
children until the last century, are rarely seen today in
industrialized countries, possibly due to improved manage-
ment of both pediatric obstructive uropathy and urinary
tract infections [38]. Nevertheless, epidemiological studies
from various countries continue to report a frequency of
struvite stones of between 25% and 38% [39–42]. Bladder
stones based on malnutrition during the first years of life
are currently a frequent finding in various areas of Turkey,
Iran, India, China, Indochina and Indonesia [43, 44],
although the incidence is proportionally decreasing as
social conditions improve. The incidence of bladder stones
Table 1 Frequency of urolithiasis according to age, stone location,
gender and stone composition in populations of different socio-
economic levels (data adapted from Asper [20] and used with
permission)
Variable Socio-economic level
Low High
Frequency in children High Low
Bladder stones (%) >40 <10
Female patients (%) <20 >25
Calcium oxalate (%) <40 >60
Uric acid (%) >30 <20
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Europe, with a steeper slope in some Asian countries where
this tendency has changed quite significantly since the
1980s [21–23, 45–48].
This trend defined, as “stone wave”, has been explained
in terms of changing social conditions and the consequent
changes in eating habits. In Europe, Northern America,
Australia, Japan, and, more recently, Saudi Arabia, afflu-
ence has spread to all social classes and with it the tendency
for individuals to increase protein intake and to eat rich
food in large quantities [19].
The Afro-Asian stone-forming belt stretches from
Sudan, the Arab Republic of Egypt, Saudi Arabia, the
United Arab Emirates, the Islamic Republic of Iran,
Pakistan, India, Myanmar, Thailand, and Indonesia to the
Philippines (Fig. 1). In this area of the world, the disease
affects all age groups, from less than 1 year old to more
than 70 years old, with a male-to-female ratio of 2 to 1. The
prevalence of calculi ranges from 4% to 20% [49]. The
higher prevalence of urolithiasis in many of those countries
is possibly determined by the high consanguinity that
prevails among ethnic groups that live in those geograph-
ical areas and which may reach 72% according to recent
studies [24].
Several studies from northeast Thailand have confirmed
the high prevalence of endemic metabolic disorders such as
renal tubular acidosis (RTA) as well as a high prevalence of
renal stone and hypocitraturia in the same population [50].
Other risk factors involved in this geographical pattern are
cultural practices such as the chewing of betel quid, which
is common in many countries of the world, particularly in
Southeast Asia. The quid consists of a preparation of areca
nut, betel leaf and calcium hydroxide ‘lime’ paste, which
produces a high incidence of hypercalciuria and hypoci-
traturia [51]. In the North Indian population the absence of
Oxalobacter formigenes, an intestinal oxalate degrading
bacteria, can lead to a significant increase in the risk of
absorptive hyperoxaluria, resulting in recurrent episodes of
calcium oxalate stones [52]. Although most of the adult
population has been found to be intestinally colonized by
Oxalobacter in other regions of the world, like the Ukraine
or Florida, USA [53], a recent paper by Kaufman et al. has
suggested that the absence of Oxalobacter is one significant
risk factor in patients with kidney stones [54].
In the USA, nephrolithiasis is said to be responsible for 1
in 7,600 to 1 in 1,000 pediatric hospital admissions [25,
55]. A recent study, however, has reported a fivefold
increase in the incidence of pediatric urolithiasis during the
past decade [26]. The incidence varies by region, but
urolithiasis is most common in the southeastern region of
the country, where the states of Virginia, North Carolina,
Georgia, Tennessee, and Kentucky are described collec-
tively as the North American “stone belt” [27] (Fig. 2).
Soucie et al. have recently published a nationwide study
that included information on self-reported, physician-
diagnosed, kidney stones collected from 1,167,009 men
and women from all 50 US states. After adjustment for age
and race, the odds of ever having had kidney stones in-
creased from west to east and from north to south. The odds
of stones among participants who resided in the southeast
were nearly twice that of those living in the northwest [56].
North American studies report that 75% of children who
have urolithiasis have an identifiable predisposition to stone
formation and metabolic risk factors such as hypercalciuria
and hyperuricosuria that account for more than 50% of
cases [57].
There are few pediatric epidemiologic studies from other
countries of the American continent. A study from
Venezuela reported that urolithiasis was responsible for
7% of general outpatient consultations in all national
children’s hospitals during 1998 [28]. In Chile, the reported
rate of pediatric urolithiasis was 1.6 in 1,000 pediatric
admissions and 4.3% of pediatric nephrology admissions
during 2003 [29].
In summary, the epidemiology of renal stones with
regard to stone composition is continuing to change all over Fig. 1 North African–Asian stone belt
Fig. 2 North American stone belt
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stones. Major differences in the frequency of the other
constituents, particularly uric acid and struvite, reflect
particular eating habits and infection risk factors specific
to certain population.
Race and gender
Idiopathic stone disease occurs more frequently in white
Caucasians than in Blacks, irrespective of the geographic
area concerned. In the USA and Brazil, the same 4 to 1
Caucasian-to-Black ratio between stone formers was report-
ed [58]. Probably, these differences cannot simply be
accounted for by inborn racial factors. Indeed, there was a
significant increase in the prevalence of urolithiasis in
Black Americans once they had adopted Caucasian dietary
habits [58]. With regard to gender distribution, the male-to-
female ratio appears to be higher in White populations than
in Black Americans and Hispanics [58–61].
Inheritance and familial recurrence
Autosomal recessive inheritance was defined for cystinuria
and primary hyperoxaluria. The reported prevalence for
cystinuria is 1–5% of all patients with urolithiasis and much
lower for primary hyperoxaluria (∼2 per million popula-
tions). These diagnoses require sophisticated procedures,
which make epidemiological surveys rather rare in under-
developed countries [62]. Prevalence rates for primary
hyperoxaluria are higher in regions with a high rate of
consanguineous marriages, such as in Northern Africa or in
Israeli Arabs [63, 64]. Cystinuria and primary hyper-
oxaluria, as well as renal tubular acidosis and Dent’s
disease, are some of the different monogenic conditions
that have been identified to date as etiologies for urolith-
iasis. However, all of these rare conditions probably
account for less than 2% of renal stones [65]. A familial
occurrence has also been suggested for hypercalciuria, one
of the main risk factors for idiopathic urolithiasis [66–69].
However, familial recurrence does not necessarily imply an
inherited transmission, as it may be an effect of environ-
mental factors shared by family members, mainly those
related to dietary habits. A study by Curhan et al. suggests
that approximately 60% of the enhanced risk of stone
formation among relatives of patients with idiopathic
urolithiasis might be related to genetic inheritance [70].
Similar results were reported by Goldfarb and colleagues
in a large twin study to examine genetic and non-
genetic factors associated with stones [71]. To date, the
available data suggest that, in the vast majority of kidney
stone formers, the mode of inheritance is complex and
polygenic.
Climate and season
It has been well documented that the incidence of urinary
stones is higher in countries with warm or hot climates,
probably due to low urinary output and scant fluid intake.
These are some of the factors that contribute to the
geographical pattern that has characterized the North
American and Afro-Asian stone belts. Also, in a given
population, stone recurrence is higher in summer and fall
than in winter and spring [48]. In a North American study
the prevalence of stones tended to increase as the average
annual temperature (5.2°C in North Dakota to 22°C in
Florida) and sunlight index (14.6 in Washington state to
39.7 in Florida) increased [56].
Dietary habits
Epidemiologic observations leave no doubt that diet plays a
major, if not the most important, role in the pathogenesis of
urolithiasis. Much evidence has been put forward that the
consumption of animal protein is closely related to the
prevalence of stone disease in a given population. Animal
protein intake has a great influence on the whole stone
forming risk and the chemical composition of urinary
calculi [72–74].
Recent studies report that actual protein consumption in
children in Europe and North America is three-time to five-
times higher than recommended [75]. A meta-analysis of
the data from a variety of studies in children has been used
to derive values for the average protein requirements and
for a safe level of protein intake. Protein requirements range
from 1.12 g/kg per day at age 6 months to 0.74 g/kg per
day at 10 years, followed by a small decline towards the
adult value in adolescence. Safe values of protein intake are
said to range from 1.43 g/kg per day at 6 months to 0.91 g/kg
per day at 10 years [76].
The higher prevalence of urolithiasis in Saudi Arabia
than in the USA and Europe has been ascribed to a high
intake of animal protein, which was 10% and 50% higher
than in the USA and Europe, respectively [18]. The
prevalence of uric acid and calcium oxalate stones also
appeared to be influenced by animal protein in the diet. In
Japan, bladder and upper urinary tract stones shared the
same prevalence in 1950, but the latter had risen to 95% by
1980. During the same interval, individual animal protein
intake in Japan rose from 20 g per day to 40 g per day [45].
This increase in upper urinary tract stone prevalence also
occurred in other eastern countries where consumption of
animal and vegetable proteins had increased during the past
decades [48].
A number of mechanisms have been proposed to explain
the metabolic changes induced with increased protein
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posed of sulfur, such as cystine and methionine, which are
more prevalent in animal protein. Sulfur is oxidized, yield-
ing sulfate, which generates an acid load that is buffered by
bone. The resultant osseous dissolution provides more
calcium to be excreted [78–81]. (2) Sulfate also forms a
soluble complex with calcium in the nephron and limits the
reabsorption of this cation. (3) Increased protein consump-
tion augments glomerular filtration, thus delivering more
calcium to the nephron [82–86]. (4) Animal protein has a
high purine content, which explains the associated increase
in uric acid excretion. This is a risk factor for the develop-
ment of uric acid stones and may play a role in calcium
stone formation. (5) Chronic metabolic acidosis induced by
the increased acid load decreases calcium reabsorption
within the nephron [85–87]. (6) The decreased urinary pH
may potentiate uric acid lithiasis, and it enhances citrate
reabsorption in the proximal tubules, thus decreasing the
excretion of this important inhibitor of crystallization [88].
(7) The augmented oxalate excretion with increasing
dietary protein reported by some investigators may be
caused by generation of more glycolate, an oxalate
precursor [89].
As well as a protein-rich diet that enhances the risk for
calcium oxalate and upper urinary tract stones, a nutrition-
ally poor diet that is low in animal protein, calcium and
phosphate but high in cereal and therefore acidogenic is the
main factor that leads to the development of bladder stones
in children in underdeveloped countries. This leads to the
formation of urine with a relatively high content of ammoni-
um and urate ions and, consequently, to the formation of
ammonium acid urate stones [21].
Sodium intake has a major role as a risk factor for stone
formation in view of the fact that high urinary sodium
excretion has been repeatedly associated with hypercalciu-
ria in adult and pediatric populations [90, 91]. Sakhaee et
al. have shown that sodium loading in healthy adult
subjects increases urinary pH and the relative supersatura-
tion ratios of brushite and monosodium urate but reduces
urinary citrate excretion and serum bicarbonate levels [92].
The increased calcium excretion is thought to be caused by
sodium-induced expansion of the volume of extracellular
fluid, resulting in inhibition of calcium reabsorption in the
nephron. The decreased citrate excretion is ascribed to the
effect that bicarbonate has on citrate metabolism in
proximal tubular cells [93]. The increase in urinary pH is
likely caused by the increased bicarbonate excretion.
An inverse relationship occurs between renal potassium
and calcium excretion, which brings attention to the role of
potassium-rich foods such as vegetables and fruits in the
prevention of stone formation [94, 95]. Potassium con-
sumption augments renal tubular phosphate absorption,
which inhibits the synthesis of 1,25-dihydroxyvitamin [96,
97]. This results in decreased intestinal absorption of
calcium, which reduces urinary calcium excretion. Another
potential benefit is that foods high in potassium content are
usually replete with alkali, which reflects the dietary intake
of actual bicarbonate or potential bicarbonate that reduces
net acid excretion and stimulates urinary citrate excretion
[98].
The importance of dairy products in the pathogenesis
and treatment of urolithiasis has been debated for decades.
Dairy products play a twofold pivotal role, being a source
of both animal protein and calcium. Curhan et al. assessed
the relative role of calcium intake as a dietary risk factor for
urolithiasis among 40,000 healthy subjects in the USA.
Their study demonstrated an increasing risk for developing
urolithiasis with decreasing calcium intake from over
1,050 mg/day to 600 mg/day [99]. These findings were
explained by the well-known effect of dietary calcium on
intestinal absorption of oxalate. The preceding arguments
and the definite importance of an adequate calcium intake
for normal bone metabolism in childhood are the basis for
avoiding restrictive dietary prescriptions that are below the
calcium requirements for different age groups.
There is evidence that carbohydrate ingestion has an
impact on certain recognized stone risk factors. Carbohy-
drate consumption induces increased urinary calcium
excretion, which has been ascribed to decreased distal
tubular calcium absorption and augmented intestinal calci-
um uptake [78, 100–102]. Several investigations have
demonstrated that urinary oxalate excretion significantly
increases after administration of a glucose load [103].
Recent studies have suggested an increased prevalence of
urolithiasis and recurrence associated with obesity, with
elevated urinary excretion of calcium, sodium, uric acid and
oxalate [104–107]. In obese patients, associated metabolic
derangements such as insulin resistance and compensatory
hyperinsulinemia may lead to the formation of calcium-
containing kidney stones [108]. A recent metabolic trial
demonstrated that insulin resistance was associated with
defects in renal ammonium ion production [109]. A defect
in renal acid excretion could lead to hypocitraturia, an
important risk factor for calcium urolithiasis. Hyperinsuli-
nemia may also contribute to the development of calcium
stones by increasing the urinary excretion of calcium [110].
It appears that the more we deviate from a traditional
balanced diet, with adequate intake of protein, calcium, salt,
fruits, and vegetables, and supplement it with rich fast
foods and artificial drinks, the more we increase our risk for
urolithiasis. Therefore, a diet that contains recommended
daily allowances of protein and calcium and is low in
sodium and oxalate and rich in potassium is recommended,
not only for children with hypercalciuria, hyperuricosuria,
Pediatr Nephrol (2010) 25:49–59 55oxaluria, and idiopathic stones, but also for the prevention
of stone formation in the pediatric and adult population.
Conclusion
Both historical and current epidemiological data show a high
variety of pathophysiological data for recurrent stone
disease. However, one observation is true for every individual
region of the world: the incidence of stone disease in children
and adolescents is increasing, as it is in adults. Hence,
knowledge of regional diversities is necessary if we are to
perform a proper examination of the patient with a kidney
stone.Theavailableevidencewithregardtotheimportanceof
dietary habits in the pathogenesis of kidney stone formation
brings forward the major role that general pediatricians and
pediatric nephrologists play in the guidance of their patients’
families with respect to adequate nutrition and fluid intake.
This kind of intervention is surely the less costly and less
painful for one of the most preventable renal conditions and
was already the most popular recommendation centuries ago!
Questions
(Answers appear following the reference list)
History
1. Historical evidence of urinary calculi has been found
from as long ago as:
a. 500 years BC
b. 1,500 years BC
c. 5,000 years BC
d. 8,000 years BC
2. The procedure of lithotomy was first mentioned
a. 3,000 years BC
b. 2,000 years BC
c. 1,000 years BC
d. 300 years BC
3. Thefirstreportonstoneremovalviatheurethracamefrom
a. Egypt
b. India
c. Arabia
d. Europe
4. The reasons for the prohibition by the Hippocratic Oath
of lithotripsy procedure in the second and third
centuries BC were the risks of complications such as:
a. High fevers
b. Urinary fistulas
c. Impotence
d. Death
5. The increase in prevalence of kidney stone disease
during the sixteenth to eighteenth centuries, specially in
Europe, was due to:
a. Changes in dietary habits
b. Increase in calorie intake
c. Increased intake of alcoholic beverages
d. All of the above
Epidemiology
6. The higher incidence of urolithiasis in countries of the
so-called North African–Asian stone belt is possibly
determined by:
a. Warm climate
b. Low protein intake
c. High consanguinity
d. High intake of cereals
7. The location of urinary calculi in economically devel-
oped countries is most frequent in the:
a. Upper urinary tract
b. Bladder
c. Urethra
d. Could be in either one
8. The trend defined as “stone wave” has been explained
in terms of:
a. Changing social conditions
b. Increase in protein intake
c. Increase in “rich” food intake
d. All of the above
9. In the United States of America an identifiable predis-
position to stone formation may be demonstrated in:
a. Fewer than 10% of patients with nephrolithiasis
b. 20–50% of patients with nephrolithiasis
c. 75% patients with nephrolithiasis
d. 80–90% patients with nephrolithiasis
10. Dietary factors that are related to high incidence of
nephrolithiasis are:
a. High protein intake
b. High sodium intake
c. Low potassium intake
d. All of the above
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Answers
1. c. 5,000 years BC.
2. d. Three centuries BC, Ammonius first mentioned that crushing
a bladder stone would make its removal much easier, for which he
received his nickname “Lithotomus” = Stein-Schneider (stone cutter).
3. b. In the sixth century BC, Sushruta, the main physician of the
king of India, first reported stone removal via the urethra using a splint.
4. e. All of the above.
5. d. The reason for this increase was the change in nutritional
habits. After the pest epidemics, nutrition improved in the sixteenth
century, with a steady increase in calorie intake. A comparable
situation was found after The 30 Years War, during the second half of
the seventeenth century and at the beginning of the eighteenth century.
Another very important risk factor explaining the increase in kidney
stone prevalence is the increased intake of alcoholic beverages and,
especially, that of wine or must, which was a common drink during
that time in all social groups, at least in Europe.
6. c. The higher incidence of urolithiasis in many of these countries
is possibly determined by the high consanguinity that prevails among
ethnic groups that live in these geographical areas.
7. a. Calculosis of the upper urinary tract featuring mainly calcium
oxalate and phosphate is currently more frequent in economically
developed countries.
8. d. The trend defined as “stone wave” was explained in terms of
changing social conditions and the consequent changes in eating
habits. In Europe, Northern America, Australia, Japan, and, more
recently, Saudi Arabia, affluence has spread to all social classes and
with it the tendency for increased protein intake and the consumption
of “rich” food in large quantities.
9. c. Studies from that country report that 75% of children who
have nephrolithiasis have an identifiable predisposition to stone
formation.
10. d. All of the above.
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